Agrawal, S., A. Gupta, S. Gupta, B. Goyal, R. A. T. Siddeek, D. Rajput, U. Chauhan, S. Kishore, M. Gupta and R. Kant (2020). "Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder." Journal of Carcinogenesis 19.
Albrecht, H., P. A. Burke, A. Natarajan, C.-Y. Xiong, M. Kalicinsky, G. L. DeNardo and S. J. DeNardo (2004). "Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand." Bioconjugate chemistry 15(1): 16-26.
Borghaei, H., M. K. Robinson and L. M. Weiner (2006). Monoclonal antibody therapy of cancer. Immunotherapy of Cancer, Springer: 487-502.
Choi, J. and S. Lee). 2004). Secretory and extracellular production of recombinant proteins using Escherichia coli." Applied microbiology and biotechnology 64(5): 625-635.
Ghasemi, F., A. Zomorodipour, S. Shojai, F. Ataei, M. Khodabandeh and M. H. Sanati (2004). "Using L-arabinose for production of human growth hormone in Escherichia coli, studying the processing of gIII:: hGH precursor."
Hall, C., L. Clarke, A. Pal, P. Buchwald, T. Eglinton, C. Wakeman and F. Frizelle (2019). "A review of the role of carcinoembryonic antigen in clinical practice." Annals of Coloproctology 35(6): 294.
Hammarström, S. (1999). The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Seminars in cancer biology, Elsevier.
Kriangkum, J., B. Xu, L. P. Nagata, R. E. Fulton and M. R. Suresh (2001). "Bispecific and bifunctional single chain recombinant antibodies." Biomolecular engineering 18(2): 31-40.
Loud, J. T. and J. Murphy (2017). Cancer screening and early detection in the 21st century. Seminars in oncology nursing, Elsevier.
Mohr, L., A. Yeung, C. Aloman, D. Wittrup and J. R. Wands (2004). "Antibody-directed therapy for human hepatocellular carcinoma." Gastroenterology 127(5): S225-S231.
Pucca, M. B., T. B. Bertolini, J. E. Barbosa, S. V. R. Galina and G. S. Porto (2011). "Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals." Brazilian Journal of Pharmaceutical Sciences 47(1): 31-38.
Raivio, T. L. and T. J. Silhavy (2001). "Periplasmic stress and ECF sigma factors." Annual review of microbiology 55: 591.
Sahlmann, C. O., K. Homayounfar, M. Niessner, J. Dyczkowski, L. C. Conradi, F. Braulke, B. Meller, T. Beißbarth, B. M. Ghadimi and J. Meller (2017). "Repeated adjuvant anti‐CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long‐term efficacy results of a prospective phase 2 study." Cancer 123(4): 638-649.
Shim, H. (2020). "Bispecific antibodies and antibody–drug conjugates for cancer therapy: technological considerations." Biomolecules 10(3): 360.
Sompunga, P., N. Pruksametanan, K. Rangnoi, K. Choowongkomon and M. Yamabhai (2019). "Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology." Talanta 201: 397-405.
Song, P., Q. Pan, Z. Sun, L. Zou and L. Yang (2022). "Fibroblast activation protein alpha: Comprehensive detection methods for drug target and tumor marker." Chemico-Biological Interactions 354: 109830.
Spindler, K.-L. G., C. Demuth, B. S. Sorensen, J. S. Johansen, D. Nielsen, N. Pallisgaard, E. Hoegdall, P. Pfeiffer and B. Vittrup Jensen (2018). "Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer." Tumor Biology 40(11): 1010428318811207.
Ten Haaf, A., S. Pscherer, K. Fries, S. Barth, S. Gattenlöhner and M. K. Tur (2015). "Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies." Immunology letters 166(2): 65-78.
Xiang, W., Q. Lv, H. Shi, B. Xie and L. Gao (2020). "Aptamer-based biosensor for detecting carcinoembryonic antigen." Talanta 214: 120716.
Yaghoubi, N., F. Z. Avval, M. Khazaei, A. Sahebkar and S. H. Aghaee-Bakhtiari (2022). "High diagnostic and prognostic value of miRNAs compared with the carcinoembryonic antigen as a traditional tumor marker." Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 22(2): 206-214.